News Story: Full Text
Sponsored By
Cedars-Siani Medical Center Brain Tumor Program
Please Click On The Above Banner For More Details
Braintumor Website

 

Novocure Announces CE Mark and First Patient Use of Second Generation Optune System

Al's Comment:

 The second generation Novocure device is now available in Europe. Hopefully will get FDA approval to use it in the USA soon!   It is half the size and weight of the old system, and looks a lot better!


Posted on: 10/05/2015

Novocure Announces CE Mark and First Patient Use of Second Generation Optune System 

 

Click for full article:

www.novocure.com/~/media/Files/N/Novocure/press-release/2015/201522-optune-europe-v5.pdf

 


Click HERE to return to brain tumor news headlines


Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740